Bruxism is a condition characterized by the involuntary clenching and grinding of teeth. This causes dental problems like worn teeth, cracked teeth fillings, and damaged dental implants. Bruxism treatment aims to provide relief from symptoms and prevent further damage to teeth. Mouth guards and other protective devices are commonly used to manage bruxism. With the advancements in technology, minimally invasive procedures like botulinum toxin injections are gaining traction.
The global Bruxism Treatment Market is estimated to be valued at US$ 1,403.76 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Demand for Minimally Invasive Procedures
Minimally invasive procedures for bruxism treatment are gaining popularity as they involve small incisions or no incisions. They enable faster recovery and cause less pain and scarring compared to traditional surgical procedures. Botulinum toxin injections involve injecting the medication into the muscles to temporarily relax them. This reduces teeth grinding and provides relief for 3-6 months. With advantages like reduced procedural time, lower risk of complications, and quick recovery, demand for minimally invasive procedures like botulinum toxin injections is increasing significantly. The attractive benefits of these procedures are expected to present lucrative growth opportunities for players in the bruxism treatment market.
Porter's Analysis
Threat of new entrants: Low as Bruxism Treatment market requires large investments in R&D to develop new treatments and therapies which act as a entry barrier.
Bargaining power of buyers: Moderate as buyers have limited options to switch between existing Bruxism Treatment products.
Bargaining power of suppliers: Moderate as suppliers have established production facilities and distribution network.
Threat of new substitutes: Low as there are limited substitute alternatives available for Bruxism Treatment.
Competitive rivalry: High due to presence of major players competing on basis of pricing, innovations and brand reputation.
SWOT Analysis
Strength: Established distribution network and brand reputation of major players. Wide range of treatment options available for patients.
Weakness: High costs associated with new drug developments. Lack of awareness among patients regarding bruxism condition and available treatments.
Opportunity: Growing geriatric population prone to bruxism and dental disorders. Emerging economies providing growth opportunities.
Threats: Stringent regulatory approvals for new treatments. Reimbursement issues hindering market growth in few regions.
Key Takeaways
The global Bruxism Treatment Market Growth is expected to witness high growth during the forecast period of 2024 to 2031. The market size for 2024 is US$ 1403.76 Bn and is projected to grow at a CAGR of 11% .
North America dominates the global market owing to presence of major players and advanced healthcare infrastructure. Growing bruxism disorders in aging population and availability of insurance coverage are driving the North America Bruxism Treatment market.
Europe accounts for the second largest share of global Bruxism Treatment market. Rising awareness about oral healthcare and availability of reimbursement are boosting the adoption of bruxism treatment in European countries.
Key players operating in the bruxism treatment market are Siemens, Abbott Laboratories, Carestream Health, Pfizer Inc. Other prominent players includes Ipsen Biopharmaceuticals, Cadila Healthcare Limited and Sanofi S.A.
Explore more related article on this topic: https://www.newsanalyticspro.com/the-global-bruxism-treatment-market-demand/
Explore more related articles: https://ceocolumn.com/blog/emergence-of-unmanned-combat-aerial-vehicles-in-modern-warfare/
https://blogger-veritas.blogspot.com/2024/01/the-global-bioinformatics-market-growth.html
